Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Back to Quotes search
BNTXBioNTech SE - ADR Live data
$87.40▲ +0.19 (0.2%)as of Nov 11, 2026, 6:10 PM UTC
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$79.52$123.98
1-Month Range
Month down -1.8%
$85.86$91.29
Daily Price Range
Day up 0.2%
$86.09$87.66
Volume
vs 1M avg
3736201M avg
Profile
Identity and capital structure
SectorUnclassified
IndustryCommon Stock
Market Cap$21.7B
Short % of Float—
Employees—
Sales$2,870M
Shares Outstanding247,928,180
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.bntx.com
BioNTech SE - ADR — BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative breast cancer, and Trastuzumab pamirtecan for metastatic breast cancer and epirubicin and cyclophosphamide; and drugs under Phase 2/3 clinical trial, such as BNT113 for human papillomavir….· via yahoo
Warnings
2 signals
Live
- ROE below 5% (-8.1%)
- Negative revenue growth (-15.1%)
Scores
0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)
Value
95
Growth
30
Quality
30
Sentiment
50
Insider Sent.
0
Piotroski F
—
Altman Z
—
Consensus rating unavailable — no analyst coverage on file for BNTX.
Price targets unavailable — no 12-month targets on file for BNTX.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on BNTX, calculate Margin of Safety, and stress-test WACC discount hurdles.
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 2 warnings surfacedNov 11, 2026, 6:10 PM UTC